Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Foresite Capital Management
Biotech
Foresite raises $900M to make fresh set of big biotech bets
Foresite's CEO says we’re in “one of the best biotech investment environments” of his career—and now has $900 million to put that belief to the test.
Nick Paul Taylor
Jun 12, 2024 9:00am
Alumis raises $259M in 2024's largest biotech round so far
Mar 6, 2024 8:00am
Troubled Theseus mulls bids from both OrbiMed and Concentra
Nov 27, 2023 9:31am
Kinnate buys OrbiMed's stake in cancer JV to go solo in China
Feb 22, 2023 9:30am
Foresite Labs nabs $173M fund for data-fueled biotechs
Mar 3, 2022 12:00pm
Novartis-backed ImmPACT Bio gets $111M, ex-Pfizer exec for CEO
Jan 20, 2022 5:00am
